UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Feasibility Trial of Pregnenolone for Posttraumatic Stress Disorder and Alcohol Use Disorder
Phase 1
Withdrawn
- Conditions
- Alcohol Use DisorderPost Traumatic Stress Disorder
- Interventions
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT04464148
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT04459468
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center, Dallas, Texas, United States
Atovaquone for Treatment of COVID-19
Phase 2
Completed
- Conditions
- COVID-19
- Interventions
- Drug: Experimental GroupDrug: Placebo Group
- First Posted Date
- 2020-07-02
- Last Posted Date
- 2021-12-14
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT04456153
- Locations
- ๐บ๐ธ
University of Texas Medical Center, Dallas, Texas, United States
Cerebellar tDCS in Children With Autism Spectrum Disorder
Not Applicable
Recruiting
- Conditions
- Autism Spectrum Disorder
- Interventions
- Device: tDCS
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT04446442
- Locations
- ๐บ๐ธ
Children's Medical Center, Dallas, Texas, United States
๐บ๐ธUniversity of Texas Southwestern, Dallas, Texas, United States
Cardiovascular Implications of COVID-19
Terminated
- Conditions
- Cardiac ComplicationSARS PneumoniaCOVID-19SARS-Associated Coronavirus as Cause of Disease Classified ElsewhereSARS-CoV 2
- First Posted Date
- 2020-06-17
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 42
- Registration Number
- NCT04435457
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy
Not Applicable
Completed
- Conditions
- Fibroid UterusAbnormal Uterine BleedingUterine BleedingSurgery
- Interventions
- Procedure: Total Laparoscopic Hysterectomy
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 46
- Registration Number
- NCT04434066
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center, Dallas, Texas, United States
The Effects of Low Dose Ketamine on Cardiovascular Function
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2024-05-21
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 6
- Registration Number
- NCT04429685
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
RCT to Compare Restrata and NPWT to Heal Complex DFUs
Phase 4
Withdrawn
- Conditions
- Diabetic Wound
- Interventions
- Device: RestrataDevice: Negative Pressure Wound Therapy (NPWT)
- First Posted Date
- 2020-05-28
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT04405050
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
Cryopreserved vs. Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds
Phase 4
Completed
- Conditions
- Diabetic Wound
- Interventions
- Device: NPWT and lyopreserved StravixDevice: NPWT and cryopreserved Stravix
- First Posted Date
- 2020-05-28
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 46
- Registration Number
- NCT04405765
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer
Phase 1
Active, not recruiting
- Conditions
- Squamous Cell Carcinoma of Head and Neck
- Interventions
- Radiation: Intensity-modulated Radiation Therapy (IMRT)
- First Posted Date
- 2020-05-27
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 59
- Registration Number
- NCT04403620
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath